Trajenta 5 mg Tablet is an anti-diabetic medication primarily used to treat type 2 diabetes in adults along with diet and lifestyle changes. It is used alone or in combination with other drugs to lower blood sugar levels. People with type 2 diabetes either do not produce enough insulin, or the insulin produced cannot perform its function in the body (insulin resistance). Middle-aged or older individuals are most likely to suffer from type 2 diabetes, also known as adult-onset diabetes.

Trajenta 5 mg Tablet contains Linagliptin, which belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors used Trajenta 5 mg Tablet is prescribed for the condition of type 2 diabetes when diet and exercise alone cannot control their blood sugar levels. It works by blocking the action of DPP-4 (an enzyme that destroys the hormone 'Incretin'). The enzyme 'Incretins' helps produce more insulin only when required and reduces the liver's blood sugar level when not needed. Trajenta 5 mg Tablet should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis.

Take Trajenta 5 mg Tablet as prescribed. However, it should be taken at the same time of the day each time for best results. Your doctor will recommend you how often you take Trajenta 5 mg Tablet based on your medical condition. The most common side effects of Trajenta 5 mg Tablet are hypoglycaemia (low blood glucose levels), upper respiratory tract infection, nasopharyngitis (infection of nose and throat with common cold), and headache.

Trajenta 5 mg Tablet should not be stopped even if you feel better, without consulting your doctor as sugar level keeps changing. If you stop taking Trajenta 5 mg Tablet abruptly, it may increase your sugar levels, which could further increase the risk of eyesight loss (retinopathy), kidney (nephropathy) and nerve damage (neuropathy). Trajenta 5 mg Tablet should not be taken if you have severe kidney or liver disease. Please inform your doctor if you have any heart disease is or planning to get pregnant or breastfeeding.

Trajenta 5 mg Tablet is primarily used to treat Type 2 diabetes mellitus. It contains Linagliptin, which belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors used Trajenta 5 mg Tablet is prescribed for type 2 diabetes when diet and exercise alone cannot control their blood sugar levels. It works by blocking the action of DPP-4 (an enzyme that destroys the hormone ‘Incretin’). The enzyme ‘Incretins’ helps produce more insulin only when required and reduces the liver's blood sugar level when not needed. Trajenta 5 mg Tablet should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis. Thus, Trajenta 5 mg Tablet plays a vital role in controlling blood sugar levels and prevents serious complications of diabetes like eyesight loss (retinopathy), kidney (nephropathy), nerve damage (neuropathy), diabetic foot ulcer and delayed wound healing.

Trajenta 5 mg Tablet should not be taken if you are allergic to Trajenta 5 mg Tablet or any of its ingredients. Please inform your doctor if you are pregnant or breastfeeding before starting Trajenta 5 mg Tablet . Prolonged intake of Trajenta 5 mg Tablet may cause acute pancreatitis (swollen pancreas), and critical kidney problem. Increased risk of hypoglycaemia (low blood sugar level) can occur when Trajenta 5 mg Tablet is added to other anti-diabetic agents or insulin therapy. In this case, your doctor may adjust the dose of Trajenta 5 mg Tablet . Severe allergic reactions might occur in some patients taking Trajenta 5 mg Tablet like anaphylaxis, angioedema (swelling under the skin), and exfoliative skin conditions including Stevens-Johnson syndrome. Safety and efficacy of Trajenta 5 mg Tablet in children under 18 years have not been established, so it should not be given to them. Patients taking digoxin (a heart medicine) with Trajenta 5 mg Tablet should be closely monitored as severe drug interaction has been observed. Trajenta 5 mg Tablet should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis.

• Keep your blood pressure as normal (140/90) as possible as it reduces the risk of cardiovascular diseases in diabetes patients.
• Monitor your blood sugar level regularly especially when there are lots of fluctuations.